Lamotrigine
SIGMA/L3791 - ≥98%, powder
Synonym: 6-
CAS Number: 84057-84-1
Empirical Formula (Hill Notation): C9H7Cl2N5
Molecular Weight: 256.09
EC Number: 281-901-8
MDL Number: MFCD00865333
Linear Formula: C9H7Cl2N5
Product Type: Chemical
| assay | ≥98% |
| color | white |
| form | powder |
| InChI | 1S/C9H7Cl2N5/c10-5-3-1-2- |
| InChI key | PYZRQGJRPPTADH-UHFFFAOYSA |
| originator | GlaxoSmithKline |
| Quality Level | 200 ![]() |
| SMILES string | Nc1nnc(c(N)n1)-c2cccc(Cl) |
| solubility | DMSO: soluble 20 mg/mL at 60 °C |
| H2O: insoluble | |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | Anticonvulsant. |
| Features and Benefits: | This compound was developed by GlaxoSmithKline . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 |
| Precautionary statements | P264 - P270 - P301 + P310 - P405 - P501 |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


